Open original FDA record ↗Recall record
- FDA identifier
- Z-1729-2019
- Company in FDA record
- Leica Microsystems, Inc.
- FDA classification date
- Jun 4, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The current labelling does not include any specific warning about usage of flammable freezing sprays. Such flammable freezing sprays can potentially ignite and can cause serious injuries.
Source facts
- Action
- Leica Biosystems notified consignees of the recall on about 05/03/2019 via "Urgent: Medical Device Recall for Cryostat Devices" letter. Instructions included to immediately attach the provided adhesive label onto the devices and add a supplemental sheet to the current instructions for use (IFU). Consignees were also instructed to provide the recall notification to all employees who need to be aware within the organization or any organization where the affected devices have been transferred, and to complete and return the response form. The form can be faxed to +1 847-236-3747 or emailed to LMGRA@ leica-microsystems.com Questions or concerns can be directed to Adam Blunier at Adam.Blunier@leicabiosystems.com. On 09/16/2019, Leica Biosystems provided an updated "Urgent: Medical Device Recall for Cryostat Devices" letter to all affected customers. The letter contained the same instructions, but instructed customers that enlarged, updated adhesive labels were provided and should be applied to affected equipment on top of the previously provided smaller label.
- Initiated
- 2019-05-03
- Root cause
- Device Design
- Terminated
- 2023-09-28
- Distribution
- Distributed to Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District Of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming. Distributed internationally to Canada.
- Recall number
- Z-1729-2019
- Recall status
- Terminated
- CDRH record ID
- 171599
- FDA classified
- 2019-06-04
- Recall event number
- 82425